当前位置:
X-MOL 学术
›
Nano-Micro Lett.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy
Nano-Micro Letters ( IF 31.6 ) Pub Date : 2024-09-30 , DOI: 10.1007/s40820-024-01533-y Yijie Wang, Congrui Liu, Chao Fang, Qiuxia Peng, Wen Qin, Xuebing Yan, Kun Zhang
中文翻译:
工程癌症纳米疫苗:癌症治疗的新领域
更新日期:2024-09-30
Nano-Micro Letters ( IF 31.6 ) Pub Date : 2024-09-30 , DOI: 10.1007/s40820-024-01533-y Yijie Wang, Congrui Liu, Chao Fang, Qiuxia Peng, Wen Qin, Xuebing Yan, Kun Zhang
-
We classified the carriers that built cancer nanovaccines, discussed their diversified applications and coincidently compared their advantages and disadvantages.
-
Various cellular targets that guide the design and engineering of cancer nanovaccines are categorized and their characteristics and benefits are highlighted.
-
The clinical cases and encountered challenges in cancer nanovaccines are discussed, during which reasonable solutions and future research direction are provided.
中文翻译:
工程癌症纳米疫苗:癌症治疗的新领域
-
我们对构建癌症纳米疫苗的载体进行了分类,讨论了它们的多样化应用,并巧合地比较了它们的优缺点。 -
对指导癌症纳米疫苗设计和工程的各种细胞靶标进行了分类,并强调了它们的特征和益处。 -
讨论了癌症纳米疫苗的临床案例和遇到的挑战,并提供了合理的解决方案和未来的研究方向。